Gut Permeability and Microbiota in Parkinson’s Disease: Mechanistic Insights and Experimental Therapeutic Strategies

Globally, Parkinson’s disease (PD) is the neurodegenerative condition with the most rapidly increasing prevalence, and a growing body of evidence associates its pathology with impairments in the gut–brain axis. Traditionally viewed as a disease marked by the loss of dopaminergic neurons, emerging ev...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:International journal of molecular sciences Ročník 26; číslo 19; s. 9593
Hlavní autoři: Liang, Yicheng, Zhao, Yuhang, Fasano, Alessio, Su, Chien-Wen
Médium: Journal Article
Jazyk:angličtina
Vydáno: Switzerland MDPI AG 01.10.2025
Témata:
alpha-Synuclein - metabolism
Animals
Blood-Brain Barrier - metabolism
Celiac disease
Cytokines
Development and progression
Fatty acids
Gastrointestinal Microbiome - physiology
Gluten
Gut microbiota
Health aspects
Homeostasis
Humans
Hypotheses
Inflammation
Kinases
Metabolites
Microbiota (Symbiotic organisms)
Neurodegeneration
Neurons
Parkinson Disease - metabolism
Parkinson Disease - microbiology
Parkinson Disease - therapy
Parkinson's disease
Pathogens
Pathology
Patients
Peptides
Permeability
Proteins
Stem cells
Toxins
Type 2 diabetes
Massachusetts
gut permeability
neuroinflammation
Parkinson’s disease (PD)
leaky gut
therapeutic approaches
gut microbiota
personalized therapy
ISSN:1422-0067, 1661-6596, 1422-0067
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Globally, Parkinson’s disease (PD) is the neurodegenerative condition with the most rapidly increasing prevalence, and a growing body of evidence associates its pathology with impairments in the gut–brain axis. Traditionally viewed as a disease marked by the loss of dopaminergic neurons, emerging evidence emphasizes that chronic neuroinflammation is a driver of neurodegeneration, with gut-originating inflammation playing a crucial role. Increased intestinal permeability, often called “leaky gut,” allows harmful substances, toxins, and misfolded α-synuclein into the systemic circulation, potentially exacerbating neuroinflammation and spreading α-synuclein pathology to the brain through the vagus nerve or compromised blood–brain barrier (BBB). This review synthesizes current insights into the relationship between gut health and PD, emphasizing the importance of gut permeability in disrupting intestinal barrier function. This paper highlights innovative therapeutic approaches, particularly personalized therapies involving gut microbiome engineering, as promising strategies for restoring gut integrity and improving neurological outcomes. Modulating specific gut bacteria to enhance the synthesis of certain metabolites, notably short-chain fatty acids (SCFAs), represents a promising strategy for reducing inflammatory responses and decelerating neurodegeneration in Parkinson’s disease.
AbstractList Globally, Parkinson’s disease (PD) is the neurodegenerative condition with the most rapidly increasing prevalence, and a growing body of evidence associates its pathology with impairments in the gut–brain axis. Traditionally viewed as a disease marked by the loss of dopaminergic neurons, emerging evidence emphasizes that chronic neuroinflammation is a driver of neurodegeneration, with gut-originating inflammation playing a crucial role. Increased intestinal permeability, often called “leaky gut,” allows harmful substances, toxins, and misfolded α-synuclein into the systemic circulation, potentially exacerbating neuroinflammation and spreading α-synuclein pathology to the brain through the vagus nerve or compromised blood–brain barrier (BBB). This review synthesizes current insights into the relationship between gut health and PD, emphasizing the importance of gut permeability in disrupting intestinal barrier function. This paper highlights innovative therapeutic approaches, particularly personalized therapies involving gut microbiome engineering, as promising strategies for restoring gut integrity and improving neurological outcomes. Modulating specific gut bacteria to enhance the synthesis of certain metabolites, notably short-chain fatty acids (SCFAs), represents a promising strategy for reducing inflammatory responses and decelerating neurodegeneration in Parkinson’s disease.
Globally, Parkinson's disease (PD) is the neurodegenerative condition with the most rapidly increasing prevalence, and a growing body of evidence associates its pathology with impairments in the gut-brain axis. Traditionally viewed as a disease marked by the loss of dopaminergic neurons, emerging evidence emphasizes that chronic neuroinflammation is a driver of neurodegeneration, with gut-originating inflammation playing a crucial role. Increased intestinal permeability, often called "leaky gut," allows harmful substances, toxins, and misfolded α-synuclein into the systemic circulation, potentially exacerbating neuroinflammation and spreading α-synuclein pathology to the brain through the vagus nerve or compromised blood-brain barrier (BBB). This review synthesizes current insights into the relationship between gut health and PD, emphasizing the importance of gut permeability in disrupting intestinal barrier function. This paper highlights innovative therapeutic approaches, particularly personalized therapies involving gut microbiome engineering, as promising strategies for restoring gut integrity and improving neurological outcomes. Modulating specific gut bacteria to enhance the synthesis of certain metabolites, notably short-chain fatty acids (SCFAs), represents a promising strategy for reducing inflammatory responses and decelerating neurodegeneration in Parkinson's disease.Globally, Parkinson's disease (PD) is the neurodegenerative condition with the most rapidly increasing prevalence, and a growing body of evidence associates its pathology with impairments in the gut-brain axis. Traditionally viewed as a disease marked by the loss of dopaminergic neurons, emerging evidence emphasizes that chronic neuroinflammation is a driver of neurodegeneration, with gut-originating inflammation playing a crucial role. Increased intestinal permeability, often called "leaky gut," allows harmful substances, toxins, and misfolded α-synuclein into the systemic circulation, potentially exacerbating neuroinflammation and spreading α-synuclein pathology to the brain through the vagus nerve or compromised blood-brain barrier (BBB). This review synthesizes current insights into the relationship between gut health and PD, emphasizing the importance of gut permeability in disrupting intestinal barrier function. This paper highlights innovative therapeutic approaches, particularly personalized therapies involving gut microbiome engineering, as promising strategies for restoring gut integrity and improving neurological outcomes. Modulating specific gut bacteria to enhance the synthesis of certain metabolites, notably short-chain fatty acids (SCFAs), represents a promising strategy for reducing inflammatory responses and decelerating neurodegeneration in Parkinson's disease.
Audience Academic
Author Liang, Yicheng
Fasano, Alessio
Su, Chien-Wen
Zhao, Yuhang
Author_xml – sequence: 1
  givenname: Yicheng
  surname: Liang
  fullname: Liang, Yicheng
– sequence: 2
  givenname: Yuhang
  surname: Zhao
  fullname: Zhao, Yuhang
– sequence: 3
  givenname: Alessio
  orcidid: 0000-0002-2134-0261
  surname: Fasano
  fullname: Fasano, Alessio
– sequence: 4
  givenname: Chien-Wen
  surname: Su
  fullname: Su, Chien-Wen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/41096858$$D View this record in MEDLINE/PubMed
BookMark eNptkstuFDEQRa0oUV6wyxpZYsOCCX70y-yiEEKkRIlEWLfc7uqZGrrdg8uNyI7f4Pf4Ejx5QBIhL2xZp275-tYe2_SjB8YOpDjU2oh3uBxIFdKY3OgNtiszpWZCFOXmo_MO2yNaCqG0ys0228mkMEWVV7vs--kU-RWEAWyDPcYbbn3LL9CFscExWo6eX9nwFT2N_vfPX8Q_IIEleM8vwC2sR4ro-JknnC8i3Vaf_FhBwAF8tD2_XkCwK5jW1OcYbIQ5Ar1gW53tCV7e7_vsy8eT6-NPs_PL07Pjo_OZ05WOM1U2ZSuTu0Y1eSZcLp0WoCSYZMq4susaKTvbKJ11eZGLVjlQYEVpTQVGlnqfvbnTXYXx2wQU6wHJQd9bD-NEtU7apSlkUST09TN0OU7Bp9fdUqKSKjP_qLntoUbfjcmTW4vWR1VuKmOkqhJ1-B8qrRYGdCm_DtP9k4JX982nZoC2XqX_s-GmfggqAW_vgBQMUYDuLyJFvZ6D-vEc6D8m9aUZ
Cites_doi 10.1111/j.1749-6632.2000.tb05244.x
10.1136/gut.28.10.1221
10.1038/s41467-020-17165-w
10.1136/gut.2008.165886
10.1007/s00401-023-02595-9
10.1038/s41385-021-00389-4
10.1186/1476-9255-8-7
10.1038/nri.2016.88
10.1001/jamanetworkopen.2024.31949
10.1016/j.exger.2021.111376
10.1007/s00535-019-01618-1
10.1016/j.parkreldis.2023.105361
10.1007/s10517-017-3700-7
10.1016/j.neuron.2019.05.035
10.1093/brain/awaa401
10.1016/S0140-6736(00)02169-3
10.3390/ijms21134714
10.1136/gutjnl-2012-304066
10.1038/s43587-021-00093-9
10.1038/s41531-025-00885-5
10.3390/cells12010191
10.1038/s41598-022-18771-y
10.1007/s12264-023-01123-9
10.1080/1028415X.2025.2558119
10.3389/fmicb.2018.02013
10.1038/s41423-023-00979-1
10.1038/s41598-022-21746-8
10.3390/foods11030268
10.1007/s00281-022-00955-3
10.1016/j.cdnut.2023.102026
10.1186/s13073-024-01335-2
10.1080/27694127.2022.2164643
10.3390/ijerph182312836
10.1016/j.jcmgh.2020.06.010
10.3390/cells11152426
10.1038/s41531-018-0058-0
10.1186/s12876-014-0189-7
10.1155/2018/2645465
10.1038/s41531-025-00945-w
10.1038/s41531-021-00156-z
10.1152/ajpgi.00412.2004
10.4103/1673-5374.308089
10.4014/jmb.2312.12031
10.1053/j.gastro.2008.03.023
10.3390/nu8110684
10.1053/j.gastro.2016.10.012
10.1038/s41392-024-01743-1
10.1007/s002530000404
10.15283/ijsc23169
10.3748/wjg.v24.i1.5
10.1038/s41575-019-0157-3
10.1016/j.nbd.2011.10.014
10.1097/WNF.0b013e318065b088
10.1016/bs.pbr.2020.01.004
10.1186/s13024-021-00427-6
10.1186/s41232-023-00269-3
10.1111/j.1365-2982.2005.00654.x
10.1016/j.ajpath.2021.09.006
10.1159/000200396
10.1016/j.yfrne.2020.100857
10.1016/j.jad.2022.11.058
10.1111/febs.14970
10.1016/j.parkreldis.2016.08.019
10.1152/ajpgi.00318.2005
10.1016/j.cell.2016.11.018
10.1093/hmg/ddx114
10.3945/jn.109.104638
10.3389/fimmu.2017.00598
10.1073/pnas.0303859101
10.1007/s00018-016-2351-6
10.3748/wjg.v21.i29.8787
10.4161/gmic.1.6.14076
10.1016/j.immuni.2015.09.003
10.1007/s00702-002-0808-2
10.1016/j.neuron.2004.10.023
10.3389/fendo.2020.00025
10.1080/19490976.2023.2284247
10.1038/s12276-018-0126-x
10.1136/gutjnl-2019-318427
10.3390/ijms26062440
10.1016/j.stem.2025.01.006
10.1126/scitranslmed.3009759
10.3748/wjg.v17.i17.2161
10.3390/ijms232214156
10.1016/j.gpb.2021.08.009
10.1111/j.1582-4934.2010.01065.x
10.1007/s12264-018-0288-5
10.3390/ijms231810235
10.3390/molecules25112502
10.1016/j.bbrc.2018.11.021
10.1155/2020/1061470
10.1038/s41587-025-02567-2
10.1016/j.nbd.2020.104782
10.1016/j.neuron.2004.11.005
10.1093/stmcls/sxae042
10.4110/in.2017.17.1.1
10.1038/s41577-021-00538-7
10.3389/fmicb.2023.1241309
10.1016/j.neuron.2014.12.007
10.1016/j.jns.2017.08.3235
10.7717/peerj.12293
10.3390/diagnostics11061090
10.3389/fnagi.2023.1151850
10.1016/j.bbi.2016.02.020
10.1161/STROKEAHA.122.040578
10.3390/nu8010044
10.1038/s12276-021-00617-8
10.2337/db09-1606
10.1038/s41586-024-07681-w
10.1038/s41531-021-00170-1
10.2174/13816128113199990462
10.1371/journal.pone.0244680
10.1080/21688370.2017.1373208
10.1515/revneuro-2021-0146
10.1186/s13059-015-0614-4
10.1136/gut.44.3.394
10.1016/j.fshw.2023.02.022
10.1002/stem.1415
10.3389/fcimb.2021.736204
10.1128/msystems.00137-18
10.1056/NEJMoa1915872
10.1016/j.parkreldis.2020.01.009
10.2337/db07-1403
10.1136/gutjnl-2017-314759
10.1016/j.cmet.2024.06.010
10.1016/S1474-4422(06)70373-8
10.1007/s11739-023-03374-w
10.1007/s10620-012-2259-4
10.1073/pnas.1415174111
10.3390/ijms21176356
10.1016/S1474-4422(19)30320-5
10.1002/mds.25736
10.3389/fmed.2022.887044
10.1016/j.cell.2006.07.024
10.4161/tisb.24978
10.3389/fimmu.2020.01994
10.1074/jbc.272.38.23729
10.1016/j.ebiom.2021.103751
10.3389/fphys.2020.593026
10.1203/01.pdr.0000250014.92242.f3
ContentType Journal Article
Copyright COPYRIGHT 2025 MDPI AG
2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: COPYRIGHT 2025 MDPI AG
– notice: 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOI 10.3390/ijms26199593
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Research Library
Research Library (Corporate)
Proquest Central Premium
ProQuest One Academic (New)
ProQuest - Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
CrossRef

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: PIMPY
  name: ProQuest Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1422-0067
ExternalDocumentID A859899128
41096858
10_3390_ijms26199593
Genre Journal Article
Review
GeographicLocations Massachusetts
GeographicLocations_xml – name: Massachusetts
GrantInformation_xml – fundername: NIH HHS
  grantid: 1R21AI144738-24
GroupedDBID ---
29J
2WC
53G
5GY
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
8G5
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AFFHD
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1I
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
ESX
F5P
FRP
FYUFA
GNUQQ
GUQSH
GX1
HH5
HMCUK
HYE
IAO
IHR
ITC
KQ8
LK8
M1P
M2O
MODMG
O5R
O5S
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
RNS
RPM
TR2
TUS
UKHRP
~8M
CGR
CUY
CVF
ECM
EIF
ESTFP
NPM
3V.
7XB
8FK
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c383t-27b7d1261b2b540c51c30e21e90679c7ffb11fab234f5650d2ce2ea07a98e9173
IEDL.DBID BENPR
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001593612000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1422-0067
1661-6596
IngestDate Sat Oct 18 23:05:13 EDT 2025
Mon Nov 03 13:22:21 EST 2025
Sat Nov 29 13:46:13 EST 2025
Sat Nov 29 10:29:23 EST 2025
Mon Oct 20 01:42:04 EDT 2025
Sat Nov 29 07:10:00 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 19
Keywords gut permeability
neuroinflammation
Parkinson’s disease (PD)
leaky gut
therapeutic approaches
gut microbiota
personalized therapy
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c383t-27b7d1261b2b540c51c30e21e90679c7ffb11fab234f5650d2ce2ea07a98e9173
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-2134-0261
OpenAccessLink https://www.proquest.com/docview/3261081249?pq-origsite=%requestingapplication%
PMID 41096858
PQID 3261081249
PQPubID 2032341
ParticipantIDs proquest_miscellaneous_3261796166
proquest_journals_3261081249
gale_infotracmisc_A859899128
gale_infotracacademiconefile_A859899128
pubmed_primary_41096858
crossref_primary_10_3390_ijms26199593
PublicationCentury 2000
PublicationDate 2025-10-01
2025-Oct-01
20251001
PublicationDateYYYYMMDD 2025-10-01
PublicationDate_xml – month: 10
  year: 2025
  text: 2025-10-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle International journal of molecular sciences
PublicationTitleAlternate Int J Mol Sci
PublicationYear 2025
Publisher MDPI AG
Publisher_xml – name: MDPI AG
References ref_94
Becker (ref_114) 2022; 20
ref_137
Dalile (ref_66) 2019; 16
Liu (ref_80) 2023; 12
ref_91
Farzi (ref_62) 2016; 56
Cani (ref_77) 2009; 58
Carloni (ref_22) 2022; 44
Cheng (ref_121) 2023; 15
ref_12
Peng (ref_102) 2009; 139
ref_131
Paiva (ref_106) 2017; 26
ref_133
Takiishi (ref_16) 2017; 5
Herrick (ref_53) 2021; 7
ref_96
ref_95
Schweitzer (ref_123) 2020; 382
Chaudhuri (ref_4) 2006; 5
Lee (ref_35) 2018; 2018
Peng (ref_76) 2007; 61
ref_19
ref_17
Wang (ref_103) 2012; 57
Mariadason (ref_101) 1999; 44
Han (ref_61) 2018; 34
Petito (ref_42) 2024; 19
Liu (ref_105) 2017; 381
Unger (ref_93) 2016; 32
Jeon (ref_125) 2025; 32
Shen (ref_118) 2018; 24
ref_23
Zimprich (ref_49) 2004; 44
ref_124
Scott (ref_132) 2015; 26
Sundberg (ref_127) 2013; 31
Kim (ref_3) 2019; 103
Kacimi (ref_64) 2011; 8
Hou (ref_110) 2021; 150
Jones (ref_89) 2020; 72
Cheng (ref_119) 2018; 3
Mitchell (ref_60) 2022; 192
Cummings (ref_99) 1987; 28
Fasano (ref_34) 2000; 915
Andjelkovic (ref_72) 2023; 54
Acar (ref_111) 2023; 110
Jin (ref_32) 2000; 54
Natah (ref_59) 2005; 17
Hu (ref_14) 2020; 2020
Aveleira (ref_37) 2010; 59
Takahashi (ref_122) 2006; 126
Bonetti (ref_47) 2024; 36
Fasano (ref_8) 2000; 355
Loh (ref_6) 2024; 9
ref_78
ref_75
ref_74
Iizuka (ref_30) 2011; 17
Recinto (ref_58) 2025; 11
Lammers (ref_31) 2008; 135
Jain (ref_50) 2004; 44
Ma (ref_38) 2005; 288
Aho (ref_92) 2021; 16
Kim (ref_126) 2025; 18
ref_83
ref_82
Ye (ref_40) 2011; 15
Akdis (ref_18) 2021; 21
Farstad (ref_29) 1994; 83
ref_140
Chang (ref_5) 2024; 7
ref_141
Chelakkot (ref_7) 2018; 50
ref_143
Cabezudo (ref_51) 2023; 146
Kars (ref_52) 2024; 16
Su (ref_98) 2020; 10
Clark (ref_129) 2024; 42
Hollville (ref_71) 2019; 286
Mishima (ref_134) 2020; 55
Braak (ref_2) 2003; 110
ref_57
ref_54
Braniste (ref_63) 2014; 6
Sartor (ref_136) 2017; 152
Salzman (ref_26) 2010; 1
Doi (ref_128) 2020; 11
Fang (ref_46) 2021; 53
Boehme (ref_115) 2021; 1
Sampson (ref_90) 2016; 167
Bzioueche (ref_43) 2014; 63
Chae (ref_10) 2024; 34
Fenton (ref_27) 2021; 14
Gates (ref_13) 2022; 33
ref_69
ref_68
Su (ref_97) 2023; 20
Stevens (ref_21) 2018; 67
ref_67
Rahman (ref_73) 2018; 507
Stacy (ref_139) 2008; 31
Keshavarzian (ref_85) 2020; 252
Pellegrini (ref_144) 2017; 74
Rudakou (ref_145) 2021; 144
Brandtzaeg (ref_28) 1990; 46
Bedarf (ref_104) 2025; 11
Kamada (ref_135) 2017; 17
Kelly (ref_20) 2014; 29
Pickrell (ref_56) 2015; 85
Cani (ref_79) 2008; 57
ref_117
ref_116
ref_36
Romano (ref_88) 2021; 7
ref_33
Garabedian (ref_25) 1997; 272
ref_113
ref_112
Leclercq (ref_11) 2014; 111
Ma (ref_120) 2021; 9
Lu (ref_86) 2013; 1
Ye (ref_39) 2006; 290
Camilleri (ref_41) 2019; 68
Johansson (ref_24) 2016; 16
Lee (ref_48) 2015; 43
Duan (ref_109) 2024; 40
Metzdorf (ref_108) 2021; 16
ref_107
ref_45
Morizane (ref_15) 2023; 43
ref_44
Jandhyala (ref_130) 2015; 21
Vijay (ref_100) 2014; 20
Abdulqadir (ref_81) 2023; 7
Nalls (ref_142) 2019; 18
Sun (ref_55) 2023; 2
Marras (ref_1) 2018; 4
ref_9
Charpenay (ref_138) 2024; 632
Wu (ref_65) 2023; 323
Petrov (ref_87) 2017; 162
Akassoglou (ref_70) 2004; 101
Cersosimo (ref_84) 2012; 46
References_xml – volume: 915
  start-page: 214
  year: 2000
  ident: ref_34
  article-title: Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin
  publication-title: Ann. N. Y Acad. Sci.
  doi: 10.1111/j.1749-6632.2000.tb05244.x
– volume: 28
  start-page: 1221
  year: 1987
  ident: ref_99
  article-title: Short chain fatty acids in human large intestine, portal, hepatic and venous blood
  publication-title: Gut
  doi: 10.1136/gut.28.10.1221
– volume: 11
  start-page: 3369
  year: 2020
  ident: ref_128
  article-title: Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-17165-w
– volume: 58
  start-page: 1091
  year: 2009
  ident: ref_77
  article-title: Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
  publication-title: Gut
  doi: 10.1136/gut.2008.165886
– volume: 146
  start-page: 245
  year: 2023
  ident: ref_51
  article-title: Mutant LRRK2 exacerbates immune response and neurodegeneration in a chronic model of experimental colitis
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-023-02595-9
– volume: 14
  start-page: 793
  year: 2021
  ident: ref_27
  article-title: Human gut-associated lymphoid tissues (GALT); diversity, structure, and function
  publication-title: Mucosal Immunol.
  doi: 10.1038/s41385-021-00389-4
– volume: 8
  start-page: 7
  year: 2011
  ident: ref_64
  article-title: Endotoxin-activated microglia injure brain derived endothelial cells via NF-κB, JAK-STAT and JNK stress kinase pathways
  publication-title: J. Inflamm.
  doi: 10.1186/1476-9255-8-7
– volume: 16
  start-page: 639
  year: 2016
  ident: ref_24
  article-title: Immunological aspects of intestinal mucus and mucins
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri.2016.88
– volume: 7
  start-page: e2431949
  year: 2024
  ident: ref_5
  article-title: Upper Gastrointestinal Mucosal Damage and Subsequent Risk of Parkinson Disease
  publication-title: JAMA Netw. Open
  doi: 10.1001/jamanetworkopen.2024.31949
– volume: 150
  start-page: 111376
  year: 2021
  ident: ref_110
  article-title: Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson’s disease
  publication-title: Exp. Gerontol.
  doi: 10.1016/j.exger.2021.111376
– volume: 55
  start-page: 4
  year: 2020
  ident: ref_134
  article-title: Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases
  publication-title: J. Gastroenterol.
  doi: 10.1007/s00535-019-01618-1
– volume: 110
  start-page: 105361
  year: 2023
  ident: ref_111
  article-title: Correlates of Zonulin and Claudin-5, markers of intestinal and brain endothelial permeability, in Parkinson’s Disease: A pilot study
  publication-title: Park. Relat. Disord.
  doi: 10.1016/j.parkreldis.2023.105361
– volume: 162
  start-page: 734
  year: 2017
  ident: ref_87
  article-title: Analysis of Gut Microbiota in Patients with Parkinson’s Disease
  publication-title: Bull. Exp. Biol. Med.
  doi: 10.1007/s10517-017-3700-7
– volume: 103
  start-page: 627
  year: 2019
  ident: ref_3
  article-title: Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease
  publication-title: Neuron
  doi: 10.1016/j.neuron.2019.05.035
– volume: 83
  start-page: 457
  year: 1994
  ident: ref_29
  article-title: Heterogeneity of M-cell-associated B and T cells in human Peyer’s patches
  publication-title: Immunology
– volume: 144
  start-page: 462
  year: 2021
  ident: ref_145
  article-title: Targeted sequencing of Parkinson’s disease loci genes highlights SYT11, FGF20 and other associations
  publication-title: Brain
  doi: 10.1093/brain/awaa401
– volume: 355
  start-page: 1518
  year: 2000
  ident: ref_8
  article-title: Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease
  publication-title: Lancet
  doi: 10.1016/S0140-6736(00)02169-3
– ident: ref_57
  doi: 10.3390/ijms21134714
– volume: 63
  start-page: 744
  year: 2014
  ident: ref_43
  article-title: Functional bowel symptoms in quiescent inflammatory bowel diseases: Role of epithelial barrier disruption and low-grade inflammation
  publication-title: Gut
  doi: 10.1136/gutjnl-2012-304066
– volume: 1
  start-page: 666
  year: 2021
  ident: ref_115
  article-title: Microbiota from young mice counteracts selective age-associated behavioral deficits
  publication-title: Nat. Aging
  doi: 10.1038/s43587-021-00093-9
– volume: 11
  start-page: 66
  year: 2025
  ident: ref_104
  article-title: A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease
  publication-title: NPJ Park. Dis.
  doi: 10.1038/s41531-025-00885-5
– ident: ref_143
  doi: 10.3390/cells12010191
– ident: ref_36
  doi: 10.1038/s41598-022-18771-y
– volume: 40
  start-page: 500
  year: 2024
  ident: ref_109
  article-title: Relationship Between Short-chain Fatty Acids and Parkinson’s Disease: A Review from Pathology to Clinic
  publication-title: Neurosci. Bull.
  doi: 10.1007/s12264-023-01123-9
– ident: ref_94
  doi: 10.1080/1028415X.2025.2558119
– ident: ref_12
  doi: 10.3389/fmicb.2018.02013
– volume: 20
  start-page: 389
  year: 2023
  ident: ref_97
  article-title: Maternal helminth infection protects offspring from high-fat-diet-induced obesity through altered microbiota and SCFAs
  publication-title: Cell Mol. Immunol.
  doi: 10.1038/s41423-023-00979-1
– ident: ref_82
  doi: 10.1038/s41598-022-21746-8
– ident: ref_83
  doi: 10.3390/foods11030268
– volume: 44
  start-page: 869
  year: 2022
  ident: ref_22
  article-title: Unveiling the gut-brain axis: Structural and functional analogies between the gut and the choroid plexus vascular and immune barriers
  publication-title: Semin. Immunopathol.
  doi: 10.1007/s00281-022-00955-3
– volume: 7
  start-page: 102026
  year: 2023
  ident: ref_81
  article-title: Role of Bifidobacterium in Modulating the Intestinal Epithelial Tight Junction Barrier: Current Knowledge and Perspectives
  publication-title: Curr. Dev. Nutr.
  doi: 10.1016/j.cdnut.2023.102026
– volume: 16
  start-page: 66
  year: 2024
  ident: ref_52
  article-title: The landscape of rare genetic variation associated with inflammatory bowel disease and Parkinson’s disease comorbidity
  publication-title: Genome Med.
  doi: 10.1186/s13073-024-01335-2
– volume: 2
  start-page: 2164643
  year: 2023
  ident: ref_55
  article-title: PRKN regulates inner mitochondrial membrane PHB2 during mitophagy
  publication-title: Autophagy Rep.
  doi: 10.1080/27694127.2022.2164643
– ident: ref_33
  doi: 10.3390/ijerph182312836
– volume: 10
  start-page: 763
  year: 2020
  ident: ref_98
  article-title: Helminth-Induced and Th2-Dependent Alterations of the Gut Microbiota Attenuate Obesity Caused by High-Fat Diet
  publication-title: Cell Mol. Gastroenterol. Hepatol.
  doi: 10.1016/j.jcmgh.2020.06.010
– ident: ref_54
  doi: 10.3390/cells11152426
– volume: 4
  start-page: 21
  year: 2018
  ident: ref_1
  article-title: Prevalence of Parkinson’s disease across North America
  publication-title: NPJ Park. Dis.
  doi: 10.1038/s41531-018-0058-0
– ident: ref_23
  doi: 10.1186/s12876-014-0189-7
– volume: 2018
  start-page: 2645465
  year: 2018
  ident: ref_35
  article-title: Tight Junction in the Intestinal Epithelium: Its Association with Diseases and Regulation by Phytochemicals
  publication-title: J. Immunol. Res.
  doi: 10.1155/2018/2645465
– volume: 11
  start-page: 133
  year: 2025
  ident: ref_58
  article-title: PINK1 deficiency rewires early immune responses in a mouse model of Parkinson’s disease triggered by intestinal infection
  publication-title: NPJ Park. Dis.
  doi: 10.1038/s41531-025-00945-w
– volume: 7
  start-page: 27
  year: 2021
  ident: ref_88
  article-title: Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation
  publication-title: Npj Park. Dis.
  doi: 10.1038/s41531-021-00156-z
– volume: 26
  start-page: 25877
  year: 2015
  ident: ref_132
  article-title: Manipulating the gut microbiota to maintain health and treat disease
  publication-title: Microb. Ecol. Health Dis.
– volume: 288
  start-page: G422–430
  year: 2005
  ident: ref_38
  article-title: Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: Role of myosin light-chain kinase protein expression
  publication-title: Am. J. Physiol. Gastrointest. Liver Physiol.
  doi: 10.1152/ajpgi.00412.2004
– volume: 16
  start-page: 2015
  year: 2021
  ident: ref_108
  article-title: Short-chain fatty acids in the context of Parkinson’s disease
  publication-title: Neural Regen. Res.
  doi: 10.4103/1673-5374.308089
– volume: 34
  start-page: 747
  year: 2024
  ident: ref_10
  article-title: Diet-Induced Gut Dysbiosis and Leaky Gut Syndrome
  publication-title: J. Microbiol. Biotechnol.
  doi: 10.4014/jmb.2312.12031
– volume: 135
  start-page: 194
  year: 2008
  ident: ref_31
  article-title: Gliadin Induces an Increase in Intestinal Permeability and Zonulin Release by Binding to the Chemokine Receptor CXCR3
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.03.023
– ident: ref_9
  doi: 10.3390/nu8110684
– volume: 152
  start-page: 327
  year: 2017
  ident: ref_136
  article-title: Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2016.10.012
– volume: 9
  start-page: 37
  year: 2024
  ident: ref_6
  article-title: Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases
  publication-title: Signal Transduct. Target. Ther.
  doi: 10.1038/s41392-024-01743-1
– volume: 54
  start-page: 311
  year: 2000
  ident: ref_32
  article-title: Intestinal receptors for adhesive fimbriae of enterotoxigenic Escherichia coli (ETEC) K88 in swine—A review
  publication-title: Appl. Microbiol. Biotechnol.
  doi: 10.1007/s002530000404
– volume: 18
  start-page: 21
  year: 2025
  ident: ref_126
  article-title: Stem Cell-Based Approaches in Parkinson’s Disease Research
  publication-title: Int. J. Stem Cells
  doi: 10.15283/ijsc23169
– volume: 24
  start-page: 5
  year: 2018
  ident: ref_118
  article-title: Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v24.i1.5
– volume: 16
  start-page: 461
  year: 2019
  ident: ref_66
  article-title: The role of short-chain fatty acids in microbiota-gut-brain communication
  publication-title: Nat. Rev. Gastroenterol. Hepatol.
  doi: 10.1038/s41575-019-0157-3
– volume: 46
  start-page: 559
  year: 2012
  ident: ref_84
  article-title: Pathological correlates of gastrointestinal dysfunction in Parkinson’s disease
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2011.10.014
– volume: 31
  start-page: 51
  year: 2008
  ident: ref_139
  article-title: Optimizing long-term therapy for Parkinson disease: Levodopa, dopamine agonists, and treatment-associated dyskinesia
  publication-title: Clin. Neuropharmacol.
  doi: 10.1097/WNF.0b013e318065b088
– volume: 252
  start-page: 357
  year: 2020
  ident: ref_85
  article-title: The gut microbiome in Parkinson’s disease: A culprit or a bystander?
  publication-title: Prog. Brain Res.
  doi: 10.1016/bs.pbr.2020.01.004
– volume: 16
  start-page: 6
  year: 2021
  ident: ref_92
  article-title: Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease
  publication-title: Mol. Neurodegener.
  doi: 10.1186/s13024-021-00427-6
– volume: 43
  start-page: 16
  year: 2023
  ident: ref_15
  article-title: Cell therapy for Parkinson’s disease with induced pluripotent stem cells
  publication-title: Inflamm. Regen.
  doi: 10.1186/s41232-023-00269-3
– volume: 17
  start-page: 433
  year: 2005
  ident: ref_59
  article-title: Disruption of the blood-brain barrier during TNBS colitis
  publication-title: Neurogastroenterol. Motil.
  doi: 10.1111/j.1365-2982.2005.00654.x
– volume: 192
  start-page: 72
  year: 2022
  ident: ref_60
  article-title: Chronic Intestinal Inflammation Suppresses Brain Activity by Inducing Neuroinflammation in Mice
  publication-title: Am. J. Pathol.
  doi: 10.1016/j.ajpath.2021.09.006
– volume: 46
  start-page: 262
  year: 1990
  ident: ref_28
  article-title: Immunomorphological characteristics of human Peyer’s patches
  publication-title: Digestion
  doi: 10.1159/000200396
– ident: ref_67
  doi: 10.1016/j.yfrne.2020.100857
– volume: 323
  start-page: 659
  year: 2023
  ident: ref_65
  article-title: Biomarkers of intestinal permeability and blood-brain barrier permeability in adolescents with major depressive disorder
  publication-title: J. Affect. Disord.
  doi: 10.1016/j.jad.2022.11.058
– volume: 286
  start-page: 3276
  year: 2019
  ident: ref_71
  article-title: Apoptotic cell death regulation in neurons
  publication-title: Febs. J.
  doi: 10.1111/febs.14970
– ident: ref_112
– volume: 32
  start-page: 66
  year: 2016
  ident: ref_93
  article-title: Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls
  publication-title: Park. Relat. Disord.
  doi: 10.1016/j.parkreldis.2016.08.019
– volume: 290
  start-page: G496
  year: 2006
  ident: ref_39
  article-title: Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier
  publication-title: Am. J. Physiol. Gastrointest. Liver Physiol.
  doi: 10.1152/ajpgi.00318.2005
– volume: 167
  start-page: 1469
  year: 2016
  ident: ref_90
  article-title: Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
  publication-title: Cell
  doi: 10.1016/j.cell.2016.11.018
– volume: 26
  start-page: 2231
  year: 2017
  ident: ref_106
  article-title: Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddx114
– volume: 139
  start-page: 1619
  year: 2009
  ident: ref_102
  article-title: Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers
  publication-title: J. Nutr.
  doi: 10.3945/jn.109.104638
– ident: ref_19
  doi: 10.3389/fimmu.2017.00598
– volume: 101
  start-page: 6698
  year: 2004
  ident: ref_70
  article-title: Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0303859101
– volume: 74
  start-page: 409
  year: 2017
  ident: ref_144
  article-title: Back to the tubule: Microtubule dynamics in Parkinson’s disease
  publication-title: Cell Mol. Life Sci.
  doi: 10.1007/s00018-016-2351-6
– volume: 21
  start-page: 8787
  year: 2015
  ident: ref_130
  article-title: Role of the normal gut microbiota
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v21.i29.8787
– volume: 1
  start-page: 401
  year: 2010
  ident: ref_26
  article-title: Paneth cell defensins and the regulation of the microbiome: Détente at mucosal surfaces
  publication-title: Gut Microbes
  doi: 10.4161/gmic.1.6.14076
– volume: 43
  start-page: 727
  year: 2015
  ident: ref_48
  article-title: Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.09.003
– volume: 110
  start-page: 517
  year: 2003
  ident: ref_2
  article-title: Idiopathic Parkinson’s disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
  publication-title: J. Neural Transm.
  doi: 10.1007/s00702-002-0808-2
– volume: 44
  start-page: 595
  year: 2004
  ident: ref_50
  article-title: Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease
  publication-title: Neuron
  doi: 10.1016/j.neuron.2004.10.023
– ident: ref_95
  doi: 10.3389/fendo.2020.00025
– volume: 15
  start-page: 2284247
  year: 2023
  ident: ref_121
  article-title: Efficacy of fecal microbiota transplantation in patients with Parkinson’s disease: Clinical trial results from a randomized, placebo-controlled design
  publication-title: Gut Microbes
  doi: 10.1080/19490976.2023.2284247
– volume: 50
  start-page: 1
  year: 2018
  ident: ref_7
  article-title: Mechanisms regulating intestinal barrier integrity and its pathological implications
  publication-title: Exp. Mol. Med.
  doi: 10.1038/s12276-018-0126-x
– ident: ref_113
– volume: 68
  start-page: 1516
  year: 2019
  ident: ref_41
  article-title: Leaky gut: Mechanisms, measurement and clinical implications in humans
  publication-title: Gut
  doi: 10.1136/gutjnl-2019-318427
– ident: ref_75
  doi: 10.3390/ijms26062440
– volume: 32
  start-page: 343
  year: 2025
  ident: ref_125
  article-title: Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson’s disease
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2025.01.006
– volume: 6
  start-page: 263ra158
  year: 2014
  ident: ref_63
  article-title: The gut microbiota influences blood-brain barrier permeability in mice
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.3009759
– volume: 17
  start-page: 2161
  year: 2011
  ident: ref_30
  article-title: Wound healing of intestinal epithelial cells
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v17.i17.2161
– ident: ref_17
  doi: 10.3390/ijms232214156
– volume: 20
  start-page: 274
  year: 2022
  ident: ref_114
  article-title: Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease—The RESISTA-PD Trial
  publication-title: Genom. Proteom. Bioinform.
  doi: 10.1016/j.gpb.2021.08.009
– volume: 15
  start-page: 970
  year: 2011
  ident: ref_40
  article-title: Cellular and molecular mechanism of interleukin-1β modulation of Caco-2 intestinal epithelial tight junction barrier
  publication-title: J. Cell Mol. Med.
  doi: 10.1111/j.1582-4934.2010.01065.x
– volume: 34
  start-page: 1058
  year: 2018
  ident: ref_61
  article-title: Cortical Inflammation is Increased in a DSS-Induced Colitis Mouse Model
  publication-title: Neurosci. Bull.
  doi: 10.1007/s12264-018-0288-5
– ident: ref_69
  doi: 10.3390/ijms231810235
– ident: ref_107
  doi: 10.3390/molecules25112502
– volume: 507
  start-page: 274
  year: 2018
  ident: ref_73
  article-title: IFN-γ, IL-17A, or zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers: Relevance for neuro-inflammatory diseases
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2018.11.021
– volume: 2020
  start-page: 1061470
  year: 2020
  ident: ref_14
  article-title: Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells
  publication-title: Stem Cells Int.
  doi: 10.1155/2020/1061470
– ident: ref_124
  doi: 10.1038/s41587-025-02567-2
– ident: ref_141
  doi: 10.1016/j.nbd.2020.104782
– volume: 44
  start-page: 601
  year: 2004
  ident: ref_49
  article-title: Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology
  publication-title: Neuron
  doi: 10.1016/j.neuron.2004.11.005
– volume: 42
  start-page: 781
  year: 2024
  ident: ref_129
  article-title: Advancing Parkinson’s disease treatment: Cell replacement therapy with neurons derived from pluripotent stem cells
  publication-title: Stem Cells
  doi: 10.1093/stmcls/sxae042
– volume: 17
  start-page: 1
  year: 2017
  ident: ref_135
  article-title: Host-microbial Cross-talk in Inflammatory Bowel Disease
  publication-title: Immune Netw.
  doi: 10.4110/in.2017.17.1.1
– volume: 21
  start-page: 739
  year: 2021
  ident: ref_18
  article-title: Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-021-00538-7
– ident: ref_116
  doi: 10.3389/fmicb.2023.1241309
– volume: 85
  start-page: 257
  year: 2015
  ident: ref_56
  article-title: The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson’s disease
  publication-title: Neuron
  doi: 10.1016/j.neuron.2014.12.007
– volume: 381
  start-page: 176
  year: 2017
  ident: ref_105
  article-title: Sodium butyrate exerts protective effect against Parkinson’s disease in mice via stimulation of glucagon like peptide-1
  publication-title: J. Neurol. Sci.
  doi: 10.1016/j.jns.2017.08.3235
– volume: 9
  start-page: e12293
  year: 2021
  ident: ref_120
  article-title: Fecal microbiota transplantation mitigates bone loss by improving gut microbiome composition and gut barrier function in aged rats
  publication-title: PeerJ
  doi: 10.7717/peerj.12293
– ident: ref_131
  doi: 10.3390/diagnostics11061090
– ident: ref_140
  doi: 10.3389/fnagi.2023.1151850
– volume: 56
  start-page: 140
  year: 2016
  ident: ref_62
  article-title: Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication
  publication-title: Brain Behav. Immun.
  doi: 10.1016/j.bbi.2016.02.020
– volume: 54
  start-page: 661
  year: 2023
  ident: ref_72
  article-title: Blood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.122.040578
– ident: ref_45
  doi: 10.3390/nu8010044
– volume: 53
  start-page: 772
  year: 2021
  ident: ref_46
  article-title: Slimy partners: The mucus barrier and gut microbiome in ulcerative colitis
  publication-title: Exp. Mol. Med.
  doi: 10.1038/s12276-021-00617-8
– volume: 59
  start-page: 2872
  year: 2010
  ident: ref_37
  article-title: TNF-α signals through PKCζ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeability
  publication-title: Diabetes
  doi: 10.2337/db09-1606
– volume: 632
  start-page: 877
  year: 2024
  ident: ref_138
  article-title: In situ targeted base editing of bacteria in the mouse gut
  publication-title: Nature
  doi: 10.1038/s41586-024-07681-w
– volume: 7
  start-page: 26
  year: 2021
  ident: ref_53
  article-title: Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
  publication-title: NPJ Park. Dis.
  doi: 10.1038/s41531-021-00170-1
– volume: 20
  start-page: 1487
  year: 2014
  ident: ref_100
  article-title: Role of monocarboxylate transporters in drug delivery to the brain
  publication-title: Curr. Pharm. Des.
  doi: 10.2174/13816128113199990462
– ident: ref_137
  doi: 10.1371/journal.pone.0244680
– volume: 5
  start-page: e1373208
  year: 2017
  ident: ref_16
  article-title: Intestinal barrier and gut microbiota: Shaping our immune responses throughout life
  publication-title: Tissue Barriers
  doi: 10.1080/21688370.2017.1373208
– volume: 33
  start-page: 767
  year: 2022
  ident: ref_13
  article-title: Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases
  publication-title: Rev. Neurosci.
  doi: 10.1515/revneuro-2021-0146
– ident: ref_78
  doi: 10.1186/s13059-015-0614-4
– volume: 44
  start-page: 394
  year: 1999
  ident: ref_101
  article-title: Modulation of distal colonic epithelial barrier function by dietary fibre in normal rats
  publication-title: Gut
  doi: 10.1136/gut.44.3.394
– volume: 12
  start-page: 1526
  year: 2023
  ident: ref_80
  article-title: Strain-specific effects of Akkermansia muciniphila on the regulation of intestinal barrier
  publication-title: Food Sci. Human. Wellness
  doi: 10.1016/j.fshw.2023.02.022
– volume: 31
  start-page: 1548
  year: 2013
  ident: ref_127
  article-title: Improved cell therapy protocols for Parkinson’s disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons
  publication-title: Stem Cells
  doi: 10.1002/stem.1415
– ident: ref_117
  doi: 10.3389/fcimb.2021.736204
– volume: 3
  start-page: e00137-18
  year: 2018
  ident: ref_119
  article-title: Fecal Microbiota Transplantation Beneficially Regulates Intestinal Mucosal Autophagy and Alleviates Gut Barrier Injury
  publication-title: mSystems
  doi: 10.1128/msystems.00137-18
– volume: 382
  start-page: 1926
  year: 2020
  ident: ref_123
  article-title: Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1915872
– volume: 72
  start-page: 7
  year: 2020
  ident: ref_89
  article-title: Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson’s disease
  publication-title: Park. Relat. Disord.
  doi: 10.1016/j.parkreldis.2020.01.009
– volume: 57
  start-page: 1470
  year: 2008
  ident: ref_79
  article-title: Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
  publication-title: Diabetes
  doi: 10.2337/db07-1403
– volume: 67
  start-page: 1555
  year: 2018
  ident: ref_21
  article-title: Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression
  publication-title: Gut
  doi: 10.1136/gutjnl-2017-314759
– volume: 36
  start-page: 1726
  year: 2024
  ident: ref_47
  article-title: A Th17 cell-intrinsic glutathione/mitochondrial-IL-22 axis protects against intestinal inflammation
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2024.06.010
– volume: 5
  start-page: 235
  year: 2006
  ident: ref_4
  article-title: Non-motor symptoms of Parkinson’s disease: Diagnosis and management
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(06)70373-8
– volume: 19
  start-page: 275
  year: 2024
  ident: ref_42
  article-title: Gut microbiota, intestinal permeability, and systemic inflammation: A narrative review
  publication-title: Intern. Emerg. Med.
  doi: 10.1007/s11739-023-03374-w
– volume: 57
  start-page: 3126
  year: 2012
  ident: ref_103
  article-title: Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription
  publication-title: Dig. Dis. Sci.
  doi: 10.1007/s10620-012-2259-4
– volume: 111
  start-page: E4485–4493
  year: 2014
  ident: ref_11
  article-title: Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1415174111
– ident: ref_96
  doi: 10.3390/ijms21176356
– volume: 18
  start-page: 1091
  year: 2019
  ident: ref_142
  article-title: Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: A meta-analysis of genome-wide association studies
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(19)30320-5
– volume: 29
  start-page: 999
  year: 2014
  ident: ref_20
  article-title: Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson’s disease
  publication-title: Mov. Disord.
  doi: 10.1002/mds.25736
– ident: ref_133
  doi: 10.3389/fmed.2022.887044
– ident: ref_91
– volume: 126
  start-page: 663
  year: 2006
  ident: ref_122
  article-title: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
  publication-title: Cell
  doi: 10.1016/j.cell.2006.07.024
– volume: 1
  start-page: e24978
  year: 2013
  ident: ref_86
  article-title: Claudins in intestines: Distribution and functional significance in health and diseases
  publication-title: Tissue Barriers
  doi: 10.4161/tisb.24978
– ident: ref_74
  doi: 10.3389/fimmu.2020.01994
– volume: 272
  start-page: 23729
  year: 1997
  ident: ref_25
  article-title: Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.272.38.23729
– ident: ref_44
  doi: 10.1016/j.ebiom.2021.103751
– ident: ref_68
  doi: 10.3389/fphys.2020.593026
– volume: 61
  start-page: 37
  year: 2007
  ident: ref_76
  article-title: Effects of Butyrate on Intestinal Barrier Function in a Caco-2 Cell Monolayer Model of Intestinal Barrier
  publication-title: Pediatr. Res.
  doi: 10.1203/01.pdr.0000250014.92242.f3
SSID ssj0023259
Score 2.4455936
SecondaryResourceType review_article
Snippet Globally, Parkinson’s disease (PD) is the neurodegenerative condition with the most rapidly increasing prevalence, and a growing body of evidence associates...
Globally, Parkinson's disease (PD) is the neurodegenerative condition with the most rapidly increasing prevalence, and a growing body of evidence associates...
SourceID proquest
gale
pubmed
crossref
SourceType Aggregation Database
Index Database
StartPage 9593
SubjectTerms alpha-Synuclein - metabolism
Animals
Blood-Brain Barrier - metabolism
Celiac disease
Cytokines
Development and progression
Fatty acids
Gastrointestinal Microbiome - physiology
Gluten
Gut microbiota
Health aspects
Homeostasis
Humans
Hypotheses
Inflammation
Kinases
Metabolites
Microbiota (Symbiotic organisms)
Neurodegeneration
Neurons
Parkinson Disease - metabolism
Parkinson Disease - microbiology
Parkinson Disease - therapy
Parkinson's disease
Pathogens
Pathology
Patients
Peptides
Permeability
Proteins
Stem cells
Toxins
Type 2 diabetes
Title Gut Permeability and Microbiota in Parkinson’s Disease: Mechanistic Insights and Experimental Therapeutic Strategies
URI https://www.ncbi.nlm.nih.gov/pubmed/41096858
https://www.proquest.com/docview/3261081249
https://www.proquest.com/docview/3261796166
Volume 26
WOSCitedRecordID wos001593612000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: ProQuest - Health & Medical Complete保健、医学与药学数据库
  customDbUrl:
  eissn: 1422-0067
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0023259
  issn: 1422-0067
  databaseCode: 7X7
  dateStart: 20000301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1422-0067
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0023259
  issn: 1422-0067
  databaseCode: BENPR
  dateStart: 20000301
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Publicly Available Content Database
  customDbUrl:
  eissn: 1422-0067
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0023259
  issn: 1422-0067
  databaseCode: PIMPY
  dateStart: 20000301
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Research Library
  customDbUrl:
  eissn: 1422-0067
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0023259
  issn: 1422-0067
  databaseCode: M2O
  dateStart: 20000301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RLUhcyrMQKJWRQJysxs7DMRdUYAs97BKhIi2nKHYcaZHIliZbqbf-Df4ev4QZJ7vt9sCFSyTLduJoxjPz2fMAeGVSuvwJHU-sjHhcVSk3Ogl5aJwow0jprMp8sQk1nWazmc6HA7d2cKtcyUQvqKuFpTPyAzQzREjaSL87_cWpahTdrg4lNLZgmzKVxSPYfj-e5l_XkCuSvlyaQC3E00Snvet7hED_YP7jZ0vwgTLzbiilm6L5hsHpFc_Rvf9d8n3YGUxOdtjzyAO45ZqHcKcvQnnxCM4_LTuWo4B2fcruC1Y2FZvM-wxNXcnmDaPYaB8m9ufyd8s-9pc6b9nEUdywT_XMjpuWcH7rZ4-v1Q1gJ1chXmyVDNe1j-Hb0fjkw2c-VGPgFlFsx6UyqhL4S0YaNPNsImwUOimcprMoq-raCFGXRkZxjVZiWEnrpCtDVerMISiMdmHULBr3FJhyCvFvYm1s0YArYxPVpiYXABQIrjYmgNcrchSnfdKNAsEKka24TrYA3hCtCtqLuHxbDiEF-BXKalUcZolGPIkqOIC9jZG4h-xm94qCxbCH2-KKfAG8XHfTTPJLa9xi2Y9ROkX-CuBJzyXrFccC4WGWZM_-_fLncFdSTWHvILgHo-5s6V7AbXvezduzfdhSM-Wf2f7A3NiayC_Yyo8n-fe_PXQERA
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtQwEB6VAmov_JcGChiJipPVxPlxjIRQRVu6anfVwyLtLcSOI22lZkuTLdobr8FL8FA8CTPxptvtgVsPnGM7Tvx5Zj57fgDe6YQuf3zLYyNCHhVFwrWKfe5rG-R-KFVapG2xCTkYpKOROlmB310sDLlVdjKxFdTFxNAZ-Q6aGYFP2kh9Ov_OqWoU3a52JTQcLI7s7AdStvpjbw_Xd1uIg_3h50M-ryrADbKxhgupZRHgaFpoNFdMHJjQtyKwis5UjCxLHQRlrkUYlWjt-IUwVtjcl7lKLZKbEMe9A3dRjktyIZOjBcELRVucLUCdx5NYJc7RPgyVvzM-PauJrFAe4CUVeFMR3DBvWzV38PB_-0GP4MHcoGa7bgc8hhVbPYH7rsTm7Clcfpk27ATVj3UJyWcsrwrWH7v8U03OxhWjyO82CO7Pz18123NXVh9Y31JUdJvImvWqmk4x6rb3_rWqCGy4CGBjXapfWz-Dr7fy0RuwWk0quwlMWonsPjYmMmie5pEOS12SgwOKO1tq7cF2t_zZuUspkiEVI5hk12HiwXvCRkaSBqdv8nnABL6FcnZlu2mskC2jgeHB1lJLlBBm-XGHmGwuoepsARcP3l49pp7kdVfZydS1kSpBPHvw3KHyasZRgOQ3jdMX_x78DawdDvvH2XFvcPQS1gVVT25dIbdgtbmY2ldwz1w24_ridbuVGHy7bWj-BdlmWk4
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VFhAX3tBAASNRcYo2cR6OKyFU2F1Yla5WqEi9pbHjSItEtm2yRXvjb_BX-nP4JczEybbbA7ceOPsRJ_k8M589D4A3KqbLH8-4keaBG-Z57CoZea6njJ95gZBJnjTFJsR4nBweyskanHexMORW2cnERlDnM01n5D00M3yPtJHsFa1bxKQ_fH984lIFKbpp7cppWIjsmcVPpG_Vu1Ef__U258PBwcfPblthwNXIzGqXCyVyH2dWXKHpoiNfB57hvpF0vqJFUSjfLzLFg7BAy8fLuTbcZJ7IZGKQ6AQ47w3YEGhk4O7a-DAYT74u6V7Am1JtPmpAN45kbN3ug0B6ven3HxVRF8oKvKIQr6qFK8Zuo_SG9_7nz3Uf7ramNtu1e-MBrJnyIdyyxTcXj-Ds07xmE1RMxqYqX7CszNn-1GamqjM2LRnFhDfhcX9-_a5Y315m7bB9Q_HSTYprNiorOt-omtGDS_US2MFFaBvrkgCb6jF8u5aXfgLr5aw0m8CEEcj7I61DjYZrFqqgUAW5PqAgNIVSDmx3UEiPbbKRFEkaQSa9DBkH3hJOUpJBuHydtaEU-BTK5pXuJpFEHo2mhwNbKz1RdujV5g49aSu7qvQCOg68XjbTSPLHK81sbvsIGSO2HXhqEbpccegjLU6i5Nm_J38FtxGR6ZfReO853OFUVrnxkdyC9fp0bl7ATX1WT6vTl-2-YnB03dj8C5ljZG8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gut+Permeability+and+Microbiota+in+Parkinson%E2%80%99s+Disease%3A+Mechanistic+Insights+and+Experimental+Therapeutic+Strategies&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Liang%2C+Yicheng&rft.au=Zhao%2C+Yuhang&rft.au=Fasano%2C+Alessio&rft.au=Su%2C+Chien-Wen&rft.date=2025-10-01&rft.pub=MDPI+AG&rft.issn=1422-0067&rft.volume=26&rft.issue=19&rft_id=info:doi/10.3390%2Fijms26199593&rft.externalDocID=A859899128
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon